FI822800A0 - Antigenbestaemning - Google Patents

Antigenbestaemning

Info

Publication number
FI822800A0
FI822800A0 FI822800A FI822800A FI822800A0 FI 822800 A0 FI822800 A0 FI 822800A0 FI 822800 A FI822800 A FI 822800A FI 822800 A FI822800 A FI 822800A FI 822800 A0 FI822800 A0 FI 822800A0
Authority
FI
Finland
Prior art keywords
antigenbestaemning
Prior art date
Application number
FI822800A
Other languages
English (en)
Other versions
FI822800L (fi
FI73322B (fi
FI73322C (fi
Inventor
Hans Brodbeck
Harald Gallati
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Publication of FI822800A0 publication Critical patent/FI822800A0/fi
Publication of FI822800L publication Critical patent/FI822800L/fi
Publication of FI73322B publication Critical patent/FI73322B/fi
Application granted granted Critical
Publication of FI73322C publication Critical patent/FI73322C/fi

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57473—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving carcinoembryonic antigen, i.e. CEA
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/81—Packaged device or kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/962—Prevention or removal of interfering materials or reactants or other treatment to enhance results, e.g. determining or preventing nonspecific binding
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/963—Methods of stopping an enzyme reaction or stabilizing the test materials
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/975—Kit
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/811—Test for named disease, body condition or organ function
    • Y10S436/813—Cancer
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S436/00—Chemistry: analytical and immunological testing
    • Y10S436/826—Additives, e.g. buffers, diluents, preservatives

Landscapes

  • Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Biomedical Technology (AREA)
  • Chemical & Material Sciences (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Food Science & Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Saccharide Compounds (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
FI822800A 1981-08-21 1982-08-11 Foerfarande foer bestaemning av karcinoembryonal antigen och i detta foerfarande anvaendbar loesning. FI73322C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH540381 1981-08-21
CH540381 1981-08-21
CH725881 1981-11-11
CH725881 1981-11-11

Publications (4)

Publication Number Publication Date
FI822800A0 true FI822800A0 (fi) 1982-08-11
FI822800L FI822800L (fi) 1983-02-22
FI73322B FI73322B (fi) 1987-05-29
FI73322C FI73322C (fi) 1987-09-10

Family

ID=25697628

Family Applications (1)

Application Number Title Priority Date Filing Date
FI822800A FI73322C (fi) 1981-08-21 1982-08-11 Foerfarande foer bestaemning av karcinoembryonal antigen och i detta foerfarande anvaendbar loesning.

Country Status (9)

Country Link
US (1) US4467031A (fi)
EP (1) EP0072902B1 (fi)
AU (1) AU554304B2 (fi)
CA (1) CA1185526A (fi)
DE (1) DE3263249D1 (fi)
DK (1) DK158246C (fi)
ES (1) ES515132A0 (fi)
FI (1) FI73322C (fi)
NO (1) NO159754C (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4578349A (en) * 1982-04-08 1986-03-25 Abbott Laboratories Immunoassay for carcinoembryonic antigen (CEA)
US4631254A (en) * 1982-12-06 1986-12-23 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
GB8317022D0 (en) * 1983-06-23 1983-07-27 Erba Farmitalia Adenocarcinoma related new antigenic determinants
JPS6015559A (ja) * 1983-07-06 1985-01-26 Shiraimatsu Shinyaku Kk アポリポ蛋白−ｂの酵素免疫測定試薬
EP0158291A3 (en) * 1984-04-10 1988-07-27 Takeda Chemical Industries, Ltd. A method for purifying carcinoembryonic antigen and a method for producing a carcinoembryonic antigen-reactive monoclonal antibody
US4686180A (en) * 1984-11-21 1987-08-11 South Alabama Medical Science Foundation Onco-fetal specific monoclonal antibodies, methods of preparation and use
US4873313A (en) * 1985-01-18 1989-10-10 Beckman Research Institute Of City Of Hope Specific hybridoma cell line and monocolonal antibodies produced from such specific hybridoma cell line and method of using such monoclonal antibodies to detect carcinoembryonic antigens
US4722889A (en) * 1985-04-02 1988-02-02 Leeco Diagnostics, Inc. Immunoassays using multiple monoclonal antibodies and scavenger antibodies
DE3609217A1 (de) * 1986-03-19 1987-09-24 Boehringer Mannheim Gmbh Verfahren und reagenz zur bestimmung eines reaktionspartners einer immunologischen reaktion
US5190864A (en) * 1986-04-15 1993-03-02 Northeastern University Enzyme amplification by using free enzyme to release enzyme from an immobilized enzyme material
US4937188A (en) * 1986-04-15 1990-06-26 Northeastern University Enzyme activity amplification method for increasing assay sensitivity
EP0253270B1 (en) * 1986-07-14 1992-09-23 Abbott Laboratories Method for diagnostic immunoassay by solid phase separation
US6013772A (en) * 1986-08-13 2000-01-11 Bayer Corporation Antibody preparations specifically binding to unique determinants of CEA antigens or fragments thereof and use of the antibody preparations in immunoassays
EP0390910B1 (en) 1988-10-17 1995-12-13 Molecular Devices Corporation Hapten derivatized capture membran and assays using such membrane
US5888728A (en) 1988-10-17 1999-03-30 Molecular Devices Corporation Hapten derivatized capture membrane and diagnostic assays using such membrane
JP2619549B2 (ja) * 1989-06-29 1997-06-11 日本商事株式会社 抗原の定量法およびそれに用いる固相
US5180828A (en) * 1990-02-09 1993-01-19 Molecular Devices Corporation Chromophoric reagents for incorporation of biotin or other haptens into macromolecules
US5200316A (en) * 1990-02-15 1993-04-06 Miles Inc. Immunoassay methods using noncross reactive cea gene family members antibodies
NZ511705A (en) * 2001-05-14 2004-03-26 Horticulture & Food Res Inst Methods and rapid immunoassay device for detecting progesterone and other steroids
AU2003210274A1 (en) * 2002-02-14 2003-09-04 Schebo Biotech Aktiengesellschaft Method for the detection of tumor markers cea, ca19.9, or ca72.4 in the stool, allowing diagnosis of gastrointestinal tumors
NZ528323A (en) * 2003-09-18 2006-05-26 Horticulture & Food Res Inst Immunoassay
US20050214882A1 (en) * 2004-03-25 2005-09-29 Ez Bio Inc. Reagents, methods and kits for the universal rapid immuno-detection
US20060084184A1 (en) * 2004-10-19 2006-04-20 Renovar Incorporated Reagents for urine-based immunological assays

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1549069A (en) * 1976-12-10 1979-08-01 Erba Farmitalia Enzyme linked immunoassay
US4180556A (en) * 1977-03-09 1979-12-25 Abbott Laboratories Pretreatment method for carcinoembryonic antigen assay
JPS5510590A (en) * 1978-05-04 1980-01-25 Wellcome Found Enzyme immunity quantity analysis
US4272504A (en) * 1978-12-14 1981-06-09 Abbott Laboratories Antibody adsorbed support method for carcinoembryonic antigen assay
US4349528A (en) * 1979-11-21 1982-09-14 The Wistar Institute Monocolonal hybridoma antibody specific for high molecular weight carcinoembryonic antigen
US4299815A (en) * 1980-02-08 1981-11-10 Hoffmann-La Roche Inc. Carcinoembryonic antigen determination
US4376110A (en) * 1980-08-04 1983-03-08 Hybritech, Incorporated Immunometric assays using monoclonal antibodies
US4466687A (en) * 1982-05-20 1984-08-21 Amp Incorporated Low profile connector providing high density application

Also Published As

Publication number Publication date
NO159754C (no) 1989-02-01
EP0072902B1 (de) 1985-04-24
ES8400147A1 (es) 1983-10-16
DE3263249D1 (en) 1985-05-30
US4467031A (en) 1984-08-21
NO159754B (no) 1988-10-24
CA1185526A (en) 1985-04-16
FI822800L (fi) 1983-02-22
NO822853L (no) 1983-02-22
DK373182A (da) 1983-02-22
EP0072902A1 (de) 1983-03-02
FI73322B (fi) 1987-05-29
FI73322C (fi) 1987-09-10
ES515132A0 (es) 1983-10-16
DK158246C (da) 1990-09-24
AU554304B2 (en) 1986-08-14
AU8705882A (en) 1983-05-12
DK158246B (da) 1990-04-16

Similar Documents

Publication Publication Date Title
BE893795A (fr) Inhalateur-doseur
FI822800L (fi) Antigenbestaemning
AT382116B (de) Geraeuschgedaempftes schienenrad
AR228298A1 (es) Cubo-rompecabezas
BE889765A (fr) Stijgerelement
ATA518981A (de) Schipaar
BE893877A (fr) Mond-en tandverzorgingsmiddel
FI823895L (fi) Heterocykliska foereningar
BE894481A (fr) Stromingsmeter
AT384100B (de) Drehrohrofen
BE891918A (fr) Draaibare schoorsteenkap
BE891837A (fr) Anthracycline-glycosides
AT385733B (de) Skibob
AT374656B (de) Maishaecksler
ATA461081A (de) Hoergeraet
BE893857A (fr) Comptoir-vitrine
AT368631B (de) Zweibein
AT371306B (de) Hoergeraet
FI824059A0 (fi) Vridsaekring
BE893123A (fr) Thienyl- et benzothienyl-t-butylamino-phenoxypropanols
ATA492281A (de) Karniese
AR222933A1 (es) Secador-escurridor
AR225979A1 (es) Tablestacado rompeolas
AT374934B (de) Kapodaster
BR6100459U (pt) Papel-madeira

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: F. HOFFMANN-LA ROCHE AG